ADHD Treatment via QEEG-Informed Neurofeedback Treatment Stratification and Predictors of Response
Is trial and error treatment allocation a thing of the past? The last 20 years have seen brain imaging techniques evolved immensely, giving mental health practitioners hope that assessments may soon clearly assign a patient to treatment with the highest likelihood of response. The field of neurofeedback is well on the way.
neuroCare Australia’s Dr Trevor Brown contributes to PsychScene Hub with a great article on treatment stratification and personalisation of Neurofeedback using QEEG and neuroCare’s leading assessment methods.
For the full article visit PsychScene Hub.
neuroCare Group
neuroCare is a global brand in neuromodulation, active in research training in medication-free applications of TMS and Neurofeedback for mental wellness. neuroCare operates therapy centers all over the world, with clinics now open across Sydney and Melbourne.